Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients
Background. Since the introduction of direct antiviral agents (DAAs), morbidity of HCV has considerably decreased but still no guidelines have been formulated in renal transplant recipients (RTRs). We studied efficacy and tolerability of direct antiviral agents in RTRs. Methods. This prospective obs...
Main Authors: | Sourabh Sharma, Debabrata Mukherjee, Ranjith K. Nair, Bhaskar Datt, Ananth Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2018/7579689 |
Similar Items
-
Urinary tract infection in renal transplant recipients at a tertiary care center in India
by: Debabrata Mukherjee, et al.
Published: (2018-01-01) -
The Impact of Hepatitis C Infection and Antiviral Therapy on clinical Outcome in Renal Transplantation Recipients
by: Rashid Awad, et al.
Published: (1999-01-01) -
Acute kidney injury due to acute cortical necrosis following vivax malaria
by: Ranjith K Nair, et al.
Published: (2019-01-01) -
Direct-acting antiviral drugs against hepatitis C virus in renal transplant recipients: Is it the dawn of an interferon-free Era?
by: Dharshan Rangaswamy, et al.
Published: (2017-01-01) -
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
by: Ming V Lin, et al.
Published: (2016-01-01)